CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy

You are currently not logged in to PHD

To view this content, please login to your account, or within the login, click 'Create an Account' for guest access.

Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy
Writing Group Chair Naveen Pereira, MD and Vice Chair Sharon Cresci, MD discuss a new scientific statement from the American Heart Association.
Recommended Videos
Pathophysiology and Immunopathogenesis of Pediatric Myocarditis
Diagnosing Pediatric Myocarditis through Echocardiography
Risks of Myocarditis in Children with COVID-19 and mRNA Vaccines
Surveillance After Pediatric Myocarditis Treatment
Initial Evaluation Diagnosis of Pediatric Myocarditis
saved video
Save Video

Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.

See Full Content
Video is not available. Please check the URL.